Results 121 to 130 of about 1,789 (171)

Long-acting HIV pre-exposure prophylaxis integrated with community-based sexual and reproductive health services in South Africa (LAPIS): study protocol for a hybrid (1a) cluster randomised controlled phase 3B trial of effectiveness and implementation

open access: yesBMC Public Health
Background Barriers and challenges associated with daily oral HIV pre-exposure prophylaxis (PrEP) contribute to poor uptake, low retention, and adherence rates among youth.
Jacob Busang   +20 more
doaj   +1 more source

Male Partner Opinions of the Dapivirine Vaginal Ring Used During an Open-Label Extension HIV Prevention Trial in KwaZulu-Natal, South Africa. [PDF]

open access: yesJ Acquir Immune Defic Syndr, 2023
Morar NS   +9 more
europepmc   +1 more source

Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial. [PDF]

open access: yesLancet HIV, 2023
Nair G   +33 more
europepmc   +1 more source

Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial. [PDF]

open access: yesJ Acquir Immune Defic Syndr, 2022
Browne EN   +13 more
europepmc   +1 more source

Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP? [PDF]

open access: yesCurr HIV/AIDS Rep, 2021
Bhavaraju N   +8 more
europepmc   +1 more source

Impact of Women's Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa. [PDF]

open access: yesAIDS Behav, 2021
Gichane MW   +12 more
europepmc   +1 more source

Women's experience receiving drug feedback and adherence counseling in MTN-025/HOPE - an HIV Prevention open-label trial of the Dapivirine Vaginal Ring. [PDF]

open access: yesAIDS Behav, 2022
Katz AWK   +13 more
europepmc   +1 more source

Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk Reduction. [PDF]

open access: yesClin Infect Dis, 2023
Steytler J   +9 more
europepmc   +1 more source

The PrEP Ring Quarterly—Edition 1, October 2024 [PDF]

open access: yes
This is the first edition of The PrEP Ring Quarterly newsletter, which provides information, updates, and resources dedicated to the dapivirine vaginal ring (DVR) also known as PrEP ...
IPM South Africa
core   +1 more source

Using Emoji Stickers to Understand End-User Opinions of the Dapivirine Vaginal Ring for HIV Prevention. [PDF]

open access: yesAIDS Behav, 2021
Katz AWK   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy